Preventive stRategy for IMMU132-relatED AEs in TNBC or Luminal Breast Cancer- PRIMED

Clinical trial NCT05520723 · COMPLETED

Trial details

NCT number: NCT05520723
Sponsor: MedSIR
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Triple Negative Breast Cancer Breast Cancer Advanced HR+/HER2- Breast Cancer

Start date: 2023-02-06
Primary completion: 2023-10-18
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.